Necrotizing Pancreatitis Lawsuit News and Information
Januvia Lawsuits
Diabetics could face an increased risk of pancreatitis as a result of Januvia side effects. The FDA indicated in September 2009 that the prescription information for the medication will be updated to include information about 88 cases of pancreatitis reported among users of the diabetes drug, including at least two cases of hemorrhagic pancreatitis [...]
All Articles Tagged With: "Necrotizing Pancreatitis"
FDA Rejects New Byetta Formula, Questions Health Risks and Manufacturing
The FDA has denied approval for a once-weekly version of Eli Lilly’s and Amylin Pharmaceuticals’ diabetes drug Byetta, saying that the agency needs answers to certain questions about the drug makers’ manufacturing processes and how it intends to mitigate Byetta health risks to users.Â
Byetta Pancreatitis Risk Needs Further Studies: FDA
The FDA has required the makers of the diabetes drug Byetta to conduct additional studies to clarify the risk of pancreatitis from side effects of their medication.
Januvia Pancreatitis Problems Refuted by Merck
Following an FDA alert issued Friday about reports of acute pancreatitis associated with use of Januvia and Janumet, Merck & Co., the maker of both diabetes drugs, issued a statement refuting that Januvia side effects increase the risk of acute pancreatitis.
Januvia Pancreatitis Warning Updated by FDA
The FDA indicated today that the prescribing information for the diabetes drugs Januvia (sitagliptin) and Janumet (sitagliptin/metformin) will be updated to provide additional information about potential pancreatitis side effects, including reported cases of acute pancreatitis, hemorrhagic pancreatitis and necrotizing pancreatitis.
Contact a Lawyer
Submit information about your potential case to be reviewed by an attorney.
